China Biopharma, Clinical Development, CRO Utilization and Outlook Report 2023: Perceptions of 101 Professionals at Domestic, Chinese Innovative Biopharmaceutical Companies
16 Jun 2023
DUBLIN, June 16, 2023 /PRNewswire/ -- The "Chinese Biopharma, Clinical Development, CRO Utilization and Outlook 2023" report has been added to
ResearchAndMarkets.com's offering.
This report takes a deep dive into the Chinese innovative biopharmaceutical market, providing groundbreaking insights into clinical development trends, activity, budget growth and preferences.
The report also details clinical development outsourcing preferences and practices to local and global Contract Research Organizations (CROs) and discusses the implications on future growth of the market. This highly strategic research should be considered foundational information for CROs, analysts and investors competing and following the evolving market.
The report examines perceptions of 101 professionals at domestic, Chinese innovative biopharmaceutical companies involved in clinical development and outsourcing to local and global Contract Research Organizations (CROs).
Topics covered include:
Clinical development trends and impact
Clinical development budget size and growth
Clinical trial composition by phase of development and outlook
Clinical development outsourcing practices by phase of development
CRO selection criteria and importance
Current clinical development outsourcing levels and growth outlook
CRO awareness and utilization
Unmet needs for clinical development services
Key Topics Covered:
I. Study Background
II. Key Conclusions and LSSG Discussion
III. Methodology
IV. Detailed Findings
Clinical Development Trends and Budget Size
Clinical Trial Characteristics by Phase and Geography
Clinical Development Outsourcing and Growth
Awareness and Utilization of Clinical Development Service Vendors Vendor Selection, Attributes and Importance
Unmet Needs
V. Respondent Demographics
VI. About the Publisher, LLC
Companies Mentioned
BOJIMed
CMIC
EPS
ICON/PRA
IQVIA
LabCorp/Covance
Leeway/Huawe Medicine
Novotech
Thermo Fisher/PPD
For more information about this report visit https://www.researchandmarkets.com/r/byu6uh
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.